Regulatory Updates

Business people team at meeting working with charts and diagrams in office

Singapore: Draft for Comments on GN-14: Guidance on the Risk Classification of In Vitro Diagnostic Medical Devices Revision 3

The Health Sciences Authority of Singapore (HSA) is soliciting the industry’s feedback on the Draft Guidance Document: GN-14 Guidance on the Risk Classification of In Vitro Diagnostic Medical Devices Revision 3. Updates in the Draft Guidance Document includes: Inclusion of Standalone software (SaMD) definition per IMDRF; Clarifications on the classification

Sign up for our regulatory roundup delivered once a month to your inbox

Scroll to Top

Contact Us

Contact Form Demo

Don’t miss a single regulatory shift in Southeast Asia!

Subscribe to our Newsletter
Be the first to know about critical medical device regulation changes, market entry requirements, and industry shifts.

Subscription Form